The immune response to Plasmodium falciparum malaria

Lancet Infectious Diseases

Volumn 2, Issue 8, 2002, Pages 472-478

  Malaguarnera, Lucia ^a   Musumeci, Salvatore ^b  

^a UNIVERSITY OF CATANIA   (Italy)

^b UNIVERSITY OF SASSARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 18; INTERLEUKIN 4; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANEMIA; BRAIN MALARIA; CELL ACTIVATION; CELL SURVIVAL; CYTOKINE PRODUCTION; IMMUNE RESPONSE; MACROPHAGE; MALARIA FALCIPARUM; NONHUMAN; PATHOPHYSIOLOGY; PHAGOCYTE; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; REVIEW;

EID: 0036319749     PISSN: 14733099     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1473-3099(02)00344-4     Document Type: Review

References (82)

1. Biology and biochemistry of sexual and sporogenic stages of Plasmodium falciparum: A review
2. Malaria vaccines
3. Evidence for limited activation of distinct CD4+ T cell subsets in response to the Plasmodium falciparum circumsporozoite protein in Papua New Guinea
4. Interferon γ and lymphotoxin or tumor necrosis factor act synergistically to induce macrophage killing of tumor cells and schistosomula or Schistosoma mansoni
5. Release of tumor necrosis factor by human polymorphonuclear neutrophils
6. Enhancement of antigen- and mitogen-induced human T lymphocyte proliferation by tumor necrosis factor alpha
7. Tumor necrosis factor-α enhances cytolitic activity of human natural killer cells
8. Cytotoxic T cells recognize a peptide from the circumsporozoite protein on malaria-infected hepatocytes
9. Protection against malaria by Plasmodium yoelii sporozoite surface protein 2 linear peptide induction of CD4+ T cell- and IFN-gamma-dependent elimination of infected hepatocytes
10. Malarial toxins and the regulation of parasite density
11. Malaria multigene families: The price of chronicity
12. Naturally acquired cellular and humoral immune responses to the major merozoite surface antigen (PfMSP1) of Plasmodium falciparum are associated with reduced malaria morbidity
13. Vaccines against the blood stages of falciparum malaria
14. The role of variant surface antigens on malaria-infected red blood cells
15. Signal transduction in host cells by a glycosyl phospatidylinositol toxin of malaria parasites
16. Plasmodium falciparum pigment induces monocytes to release high levels of tumor necrosis factor-alpha and interleukin-1 beta
17. Erythrocyte stages of Plasmodium falciparum exhibit a high nitric oxide synthase (NOS) activity and release an NOS-inducing soluble factor
18. Biochemical characterization of Plasmodium falciparum haemozoin
19. Malaria pigment in leucocytes
20. Tumor necrosis factor alpha interferon gamma and macrophage stimulating factor in relation to the severity of Plasmodium falciparum malaria in the Brazilian Amazon
21. Effects of Plasmodium vinckei haemozoin on the production of oxygen radicals and nitrogen oxides in murine macrophages
22. Impairment of macrophage functions after ingestion of Plasmodium falciparum-infected erythrocytes or isolated malarial pigment
23. The heme moiety of malaria pigment (beta-hematin) mediates the inhibition of nitric oxide and tumor necrosis factor-alpha production by lipopolysaccharide-stimulated macrophages
24. Phagocytosis of the malarial pigment, haemozoin, impairs expression of major histocompatibility complex class II antigen, CD54, and CD11c in human monocytes
25. The biological basis of malarial disease
26. Interleukin 12 induction of interferon gamma-dependent protection against malaria
27. Glycosylphosphatidylinositol toxin of Plasmodium induces nitric oxide synthase expression in macrophages and vascular endothelial cells by a protein tyrosine kinase-dependent and protein kinase C-dependent signaling pathway
28. Inducible nitric oxide synthase expression is increased in the brain in fatal cerebral malaria
29. Association between serum levels of reactive nitrogen intermediates and coma in children with cerebral malaria in Papua New Guinea
30. Nitric oxide in Tanzanian children with malaria: Inverse relationship between malaria severity and nitric oxide production/nitric oxide synthase type 2 expression
31. Loss of cellular immune reactivity during acute Plasmodium falciparum malaria
32. The immunology of malaria
33. Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria
34. Low interleukin-12 activity in severe Plasmodium falciparum malaria
35. Regulation of host cell function by glycosylphosphatidylinositols of the parasitic protozoa
36. A monoclonal antibody that recognizes phosphatidylinositol inhibits induction of tumor necrosis factor alpha by different strains of Plasmodium falciparum
37. Plasma levels of tumor necrosis factor during a longitudinal survey in an endemic area of malaria
38. IL-4 down-regulates interleukin-1 and TNF gene expression in human monocytes
39. IL-10 inhibits cytokine production by activated macrophages
40. Strain variation in tumor necrosis factor induction by parasites from children with acute falciparum malaria
41. Influence of tumor necrosis factor-alpha on the ability of monocytes and lymphocytes to destroy intraerythrocytic Plasmodium falciparum in vitro
42. Interleukin 12 and tumor necrosis factor alpha are costimulators of interferon gamma production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist
43. Tumor necrosis factor in the pathogenesis of infections diseases
44. The role of CD4+ T cells in immunity to malaria sporozoites
45. Interferon-gamma responses are associated with resistance to reinfection with Plasmodium falciparum in young African children
46. Mechanisms underlying the monocyte-mediated antibody-dependent killing of Plasmodium falciparum asexual blood stages
47. Malarial parasites induce TNF production by macrophages
48. The role of T lymphocytes in immunity to Plasmodium falciparum. Enhancement of neutrophil-mediated parasite killing by lymphotoxin and IFN-gamma: Comparisons with tumor necrosis factor effects
49. Transgenic mice in the study of cytokine function
50. Co-localization of inducible-nitric oxide synthase and Plasmodium berghei in hepatocytes from rats immunized with irradiated sporozoites
51. Frequency of cytokine-producing T cells in patients of different age groups with Plasmodium falciparum malaria
52. Is T cell priming required for initiation of pathology in malaria infections?
53. Interleukin-12: A proinflammatory cytokine with immunoregulatory functions that bridge innate resistence and antigen-specific adaptative immunity
54. Interleukin 12 and malaria
55. The molecular basis of T helped and T helper 2 cell differentiation
56. Increased levels of Interleukin-12 in Plasmodium falciparum malaria: Correlation with the severity of disease
57. Cloning a new cytokine that induces IFN-γ cells by T cells
58. A newly defined interleukin-1?
59. Interleukin 18
60. Selective expression and functions of interleukin 18 receptor on T helper (Th) type 1 but not Th2 cells
61. IL-12 upregulates interleukin-18 receptor expression on T-cells, Th1 cells, and B cells: Synergism with interleukin-18 for IFN-γ production
62. Serum levels of interleukin-18 in patients with uncomplicated Plasmodium falciparum malaria
63. IL-4-secreting CD4+ T cells are crucial to the development of CD8+ T-cell responses against malaria liver stages
64. IL-4 inhibits macrophage-mediated killing of Plasmodium falciparum in vitro. A possible parasite-immune evasion mechanism
65. Production of activated T cells of interleukin 4 but not interferon-gamma is associated with elevated levels of serum antibodies to activating malaria antigens
66. Deactivation of macrophages
67. TGF-β contributes to the shift toward Th2-type response through direct and interleukin-10-mediated pathways in tumor bearing mice
68. Upregulation of cytokine mRNA, adhesion molecule proteins, and MHC class II proteins in salivary glands of TGF-beta1 knockout mice: MHC class II is a factor in the pathogenesis of TGF-beta1 knockout mice
69. Human vascular endothelial cell adhesion receptors for Plasmodium falciparum-infected erythrocytes: Roles for endothelial leukocyte adhesion molecule 1 and vascular cell adhesion molecule 1
70. Killing of Plasmodium falciparum by cytokine activated effector cells (neutrophils and macrophages)
71. Maintaining the immunological balance in parasitic infections: A role for TGF-beta?
72. Transforming growth factor-beta 1 is required for secretion of IgG of all subclasses by LPS-activated murine B cells in vitro
73. Regulation of antibody production and class switching by TGF-beta
74. A dichotomous role for nitric oxide in protection against blood stage malaria infection
75. Decreased serum levels of TGF-beta in patients with acute Plasmodium falciparum malaria
76. Differential cellular accumulation of transforming growth factor-beta1, -beta2, and -beta3 in brains of patients who died with cerebral malaria
77. Elevated serum levels of interleukin-10 and IFN-gamma in patients with acute Plasmodium falciparum malaria
78. IL-10-induced anergy in peripheral T cell and reactivation by microenvironmental cytokines: Two key steps in specific immunotherapy
79. Interleukin-10 modulates susceptibility in experimental cerebral malaria
80. Cytokines and malaria parasitemia
81. Low plasma concentrations of interleukin 10 in severe malarial anaemia compared with cerebral and uncomplicated malaria
82. A low IL-10 tumor necrosis factor-alpha ratio is associated with malaria anemia in children residing in a holoendemic malaria region in western Kenya